Medexus Pharmaceuticals Inc (TSE:MDP) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Medexus Pharmaceuticals has successfully concluded negotiations with the pan-Canadian Pharmaceutical Alliance to make Trecondyv, a treosulfan injection, accessible through public drug programs in Canada. This milestone reflects the high demand for Trecondyv in the country and strengthens its market potential. The decision now awaits final approval for public reimbursement by government organizations.
For further insights into TSE:MDP stock, check out TipRanks’ Stock Analysis page.
